CHRONIC KIDNEY DISEASE IS NOT CHARACTERISED SOLELY BY THOSE STARTING RENAL REPLACEMENT THERAPY

被引：0
|
作者：
Adegbija, O. [1 ,2 ,3 ,8 ]
Hoy, W. E. [1 ,2 ,3 ,8 ]
Wang, Z. [1 ,2 ,3 ]
Cameron, A. [1 ,2 ,3 ,4 ,5 ]
Healy, H. G. [1 ,4 ,5 ]
Tan, K. S. [1 ,6 ]
Venuthurupalli, S. K. [1 ,2 ,3 ,7 ]
机构：
[1] Univ Queensland, Sch Med, Brisbane, Qld, Australia
[2] NHMRC CKD CRE, Brisbane, Qld, Australia
[3] CKD QLD, Brisbane, Qld, Australia
[4] Kidney Hlth Serv RBWH, Brisbane, Qld, Australia
[5] Metro North Hosp & Hlth Serv, Brisbane, Qld, Australia
[6] Metro South Hosp & Hlth Serv, Renal Serv Logan, Logan, Qld, Australia
[7] Darling Downs Hosp & Hlth Serv, Toowoomba Hosp, Renal Serv, Toowoomba, Qld, Australia
[8] Australia & New Zealand Dialysis & Transplantat R, Adelaide, SA, Australia
来源：
NEPHROLOGY | 2018年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：24 / 25
页数：2
相关论文
共 50 条
  • [31] New Aspects in the Management of Hypertension in Patients with Chronic Kidney Disease not on Renal Replacement Therapy
    Damianaki, Aikaterini
    Polychronopoulou, Erietta
    Wuerzner, Gregoire
    Burnier, Michel
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2022, 29 (02) : 125 - 135
  • [32] New Aspects in the Management of Hypertension in Patients with Chronic Kidney Disease not on Renal Replacement Therapy
    Aikaterini Damianaki
    Erietta Polychronopoulou
    Gregoire Wuerzner
    Michel Burnier
    High Blood Pressure & Cardiovascular Prevention, 2022, 29 : 125 - 135
  • [33] Secular trends in kidney disease: is the decreased incidence of renal replacement therapy due to a decrease in chronic kidney disease incidence?
    Thorp, M. L.
    Weinstein, J. R.
    Johnson, E. S.
    Yang, X.
    Smith, D. H.
    CLINICAL NEPHROLOGY, 2008, 70 (03) : 187 - 193
  • [34] Frequency of Fabry disease in chronic kidney disease patients including patients on renal replacement therapy in Korea
    Cho, Eunjung
    Park, Jung Tak
    Yoo, Tae-Hyun
    Kim, Soo Wan
    Park, Cheol Whee
    Han, Seung Seok
    Kim, Yeong Hoon
    Kwon, Young Joo
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2024, 43 (01) : 71 - 81
  • [35] Estrogen replacement therapy: effects of starting age on final height of girls with chronic kidney disease and short stature
    Amirkashani, Davoud
    Rohani, Farzaneh
    Khodadost, Mahmoud
    Hoseini, Rozita
    Alidoost, Hamidreza
    Madani, Sedigheh
    BMC PEDIATRICS, 2022, 22 (01)
  • [36] Estrogen replacement therapy: effects of starting age on final height of girls with chronic kidney disease and short stature
    Davoud Amirkashani
    Farzaneh Rohani
    Mahmoud Khodadost
    Rozita Hoseini
    Hamidreza Alidoost
    Sedigheh Madani
    BMC Pediatrics, 22
  • [37] Testosterone Replacement Therapy in Chronic Kidney Disease Patients
    Skiba, Ryszard
    Rymarz, Aleksandra
    Matyjek, Anna
    Dymus, Jolanta
    Wozniak-Kosek, Agnieszka
    Syrylo, Tomasz
    Zielinski, Henryk
    Niemczyk, Stanislaw
    NUTRIENTS, 2022, 14 (16)
  • [38] Associations between plasma lysophospholipids concentrations, chronic kidney disease and the type of renal replacement therapy
    Michalczyk, Anna
    Dolegowska, Barbara
    Heryc, Rafal
    Chlubek, Dariusz
    Safranow, Krzysztof
    LIPIDS IN HEALTH AND DISEASE, 2019, 18 (1)
  • [39] Use of Procalcitonin in Patients With Various Degrees of Chronic Kidney Disease Including Renal Replacement Therapy
    Grace, Eddie
    Turner, R. Mackenzie
    CLINICAL INFECTIOUS DISEASES, 2014, 59 (12) : 1761 - 1767
  • [40] Morbidity, mortality, and renal replacement therapy for chronic kidney disease in Mexico between 2016 and 2018
    Alberto Dorantes-Carrillo, Luis
    Medina-Escobedo, Martha
    Aridai Coba-Canto, Yaseth
    Alvarez-Baeza, Alberto
    Mendez Dominguez, Nina
    NEFROLOGIA, 2022, 42 (03): : 351 - 354
12345